Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 4376-4384, August 15, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flessner, M. F.
Right arrow Articles by Dedrick, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flessner, M. F.
Right arrow Articles by Dedrick, R. L.

Monoclonal Antibody Delivery to Intraperitoneal Tumors in Rats: Effects of Route of Administration and Intraperitoneal Solution Osmolality

Michael F. Flessner1 and Robert L. Dedrick

Laboratory of Kidney and Electrolyte Metabolism, National Heart, Lung, and Blood Institute [M. F. F.], and Biomedical Engineering and Instrumentation Program [R. L. D.], National Center for Research Resources, NIH, Bethesda, Maryland 20892

Monoclonal antibody (MAb) transport in peritoneal tissue is dominated by convection, which is dependent on the net driving force of i.p. hydrostatic and osmotic pressure. To test the hypothesis that the i.p. osmolality has significant effects on IgG delivery to the tumor during the acute period after injection, solid tumors (FEMX-II) were transplanted into the anterior abdominal wall of nude rats. The wall is subject to well-defined pressure forces from the solution in the cavity. MAb 96.5, which specifically binds to FEMX-II cells, was simultaneously injected i.v. (111In-MAb 96.5 in Krebs Ringer solution) and i.p. (125I-MAb 96.5 in dialysis solution). Intraperitoneal hydrostatic pressure was held constant, and the osmolality of the i.p. solution was varied between isotonic and hypertonic (with the addition of 4% mannitol to an isotonic salt solution) in order to vary the direction of net convection. Plasma and peritoneal concentrations of both isotopes were measured at intervals over 200 min, and tissue concentration profiles in tumor and adjacent normal tissue were determined by dual-label quantitative autoradiography at 200 min. After i.v. administration, profiles were relatively flat and little affected by i.p. osmolality. After i.p. injection, profiles demonstrated steep concentration decreases from the peritoneal surface into the tissue for several hundred µm. Despite the change from the condition of water absorption from the cavity into the body (isotonic solution) to one of net volume gain by the cavity (hypertonic solution), tumor profiles were affected by i.p. osmolality only near the surface. Specific binding properties of the tumor were determined for the tumors studied and were consistent with high surface concentrations relative to normal tissue. Variation of the i.p. solution osmolality by changes in concentration of small molecules exerts only minor effects on the short-term MAb delivery from either systemic or regional administration to a target tumor in the anterior abdominal wall in the rat.

1 To whom requests for reprints should be addressed, at University of Rochester School of Medicine and Dentistry, Strong Memorial Hospital, 601 Elmwood Ave, Box 675, Rochester, NY 14642.

Received 1/20/94. Accepted 6/14/94.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
J. Choi, K. Credit, K. Henderson, R. Deverkadra, Z. He, H. Wiig, H. Vanpelt, and M. F. Flessner
Intraperitoneal immunotherapy for metastatic ovarian carcinoma: resistance of intratumoral collagen to antibody penetration.
Clin. Cancer Res., March 15, 2006; 12(6): 1906 - 1912.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. F. Flessner, J. Choi, K. Credit, R. Deverkadra, and K. Henderson
Resistance of Tumor Interstitial Pressure to the Penetration of Intraperitoneally Delivered Antibodies into Metastatic Ovarian Tumors
Clin. Cancer Res., April 15, 2005; 11(8): 3117 - 3125.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. F. Flessner, J. Choi, Z. He, and K. Credit
Physiological characterization of human ovarian cancer cells in a rat model of intraperitoneal antineoplastic therapy
J Appl Physiol, October 1, 2004; 97(4): 1518 - 1526.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. R. Hamblin, J. L. Miller, I. Rizvi, B. Ortel, E. V. Maytin, and T. Hasan
Pegylation of a Chlorine6 Polymer Conjugate Increases Tumor Targeting of Photosensitizer
Cancer Res., October 1, 2001; 61(19): 7155 - 7162.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. F. Flessner
Transport of protein in the abdominal wall during intraperitoneal therapy. I. Theoretical approach
Am J Physiol Gastrointest Liver Physiol, August 1, 2001; 281(2): G424 - G437.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. A. Netti, L. M. Hamberg, J. W. Babich, D. Kierstead, W. Graham, G. J. Hunter, G. L. Wolf, A. Fischman, Y. Boucher, and R. K. Jain
Enhancement of fluid filtration across tumor vessels: Implication for delivery of macromolecules
PNAS, March 16, 1999; 96(6): 3137 - 3142.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. F. Flessner, J. Lofthouse, and E. R. Zakaria
In vivo diffusion of immunoglobulin G in muscle: effects of binding, solute exclusion, and lymphatic removal
Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2783 - H2793.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.